Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status
Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.8b00136
Source: Journal of Medicinal Chemistry - Category: Chemistry Authors: Xiaoyang Li, Yuri K. Peterson, Elizabeth S. Inks, Richard A. Himes, Jiaying Li, Yingjie Zhang, Xiujie Kong and C. James Chou Source Type: research